Skip to main content
. 2021 Mar 26;12:654602. doi: 10.3389/fpsyt.2021.654602

Table 1.

Demographic and clinical information of the study cohort.

HV CHR FEP P-valuea
N 40 47 103
Age, years (mean ± SD [min, max]) 28.6 ± 8.9 [18, 58] 23.3 ± 4.6 [17, 35] 29.5 ± 9.3 [16, 69] ≤0.001
Gender (male/female) 25/15 38/9 58/45 0.012
Ethnicityb 39/1/0/0 47/0/0/0 96/3/3/1 0.550
Educationc (≥13 years/ <13 years/unknown) 32/6/2 24/23/0 43/51/9 ≤0.001
Antipsychotic medication (%) 0 0 0
PANSS total (median [min, 25th, 75th, max], n) 70 [36, 55.75, 83.25, 104], 38 93 [45, 75.5, 107.5, 143], 97
PANSS positive (median [min, 25th, 75th, max], n) 15.5 [8, 12, 18, 24], 38 21 [10, 18, 26.5, 38], 97
PANSS negative (median [min, 25th, 75th, max], n) 17.5 [7, 11, 21, 32], 38 24 [9, 17, 29, 40], 97
PANSS general (median [min, 25th, 75th, max], n) 36 [21, 29, 44, 54], 38 48 [24, 38.5, 54, 73], 97
a

ANOVA or Fisher's Exact Test.

b

Caucasian/African/Asian/Other.

c

percentage that completed at least 13 years, a high-school diploma equivalent.